Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-06-09
1999-02-23
Stockton, Laura L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514461, 514570, 514718, 514532, 549 78, 549497, 549502, 560 55, 562465, 568648, A61K 3138, A61K 3134, C07D33316, C07D30736
Patent
active
058744606
ABSTRACT:
Compounds of the formula ##STR1## where W is (CH.sub.2).sub.n where n is 1 or 2, or n is 0 and W represents lower alkyl groups attached to each oxygen;
REFERENCES:
patent: 5066644 (1991-11-01), Poli et al.
patent: 5091528 (1992-02-01), Gluchowski
patent: 5151440 (1992-09-01), Gluchowski
patent: 5369127 (1994-11-01), Burk et al.
Bito, L. Z., Applied Pharmacology in the Medical Treatment of Glaucomas, Drance, S. M. and Neufeld, A. H. eds., New York, Grune & Stratton. 1984 pp. 477-505.
Journal of Medicinal Chemistry 1975, vol. 18, pp. 1094-1098 by Bender et al.
Bito, L. Z., Biological Protection with Prostaglandins, Cohen, M.M., ed., Boca Raton Fla. CRC Press Inc., 1985, pp. 231-252.
M. S. Starr, Exp. Eye Res. 11, 170-177 (1971).
Barreiro et al., J. Chem Res. Symop., 7 pp. 220-221 (1985).
Burk Robert M.
Woodward David F.
Allergan Sales Inc.
Baran Robert J.
Stockton Laura L.
Szekeres Gabor L.
Voet Martin A.
LandOfFree
1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular h does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular h, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular h will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-307487